Plasma MiR-195-5p Predicts the Severity of Covid-19 in Hospitalized Patients
Authors
Affiliations
Predicting the clinical course of Covid-19 is a challenging task, given the multi-systemic character of the disease and the paucity of minimally invasive biomarkers of disease severity. Here, we evaluated the early (first two days post-admission) level of circulating hsa-miR-195-5p (miR-195, a known responder to viral infections and SARS-CoV-2 interactor) in Covid-19 patients and assessed its potential as a biomarker of disease severity. We show that plasma miR-195 correlates with several clinical and paraclinical parameters, and is an excellent discriminator between the severe and mild forms of the disease. Our Gene Ontology analysis of miR-195 targets differentially expressed in Covid-19 indicates a strong impact on cardiac mitochondria homeostasis, suggesting a possible role in long Covid and chronic fatigue syndrome (CFS) syndromes.
Changes in miRNA Pattern Expression Associated With COVID-19 Severity.
Zarate-Segura P, Martinez-Castillo M, Garduno-Gutierrez A, Hernandez-Hernandez J, Cano-Martinez L, Garcia-Mena J In Vivo. 2024; 39(1):482-490.
PMID: 39740904 PMC: 11705121. DOI: 10.21873/invivo.13852.
SARS-CoV-2 Vaccine Improved Hemostasis of a Patient with Protein S Deficiency: A Case Report.
Mohammad M, Malik A, Thangada L, Polania-Villanueva D, Zabaleta J, Majumder R Int J Mol Sci. 2024; 25(19).
PMID: 39409046 PMC: 11477061. DOI: 10.3390/ijms251910717.
Belete M, Anley D, Tsega S, Moges N, Anteneh R, Zemene M BMC Infect Dis. 2024; 24(1):1011.
PMID: 39300343 PMC: 11414062. DOI: 10.1186/s12879-024-09915-8.
The relationship between microRNAs and COVID-19 complications.
Kebriaei A, Besharati R, Namdar Ahmad Abad H, Havakhah S, Khosrojerdi M, Azimian A Noncoding RNA Res. 2024; 10:16-24.
PMID: 39296641 PMC: 11406673. DOI: 10.1016/j.ncrna.2024.08.007.
Tsamou M, Kremers F, Samaritakis K, Roggen E Int J Mol Sci. 2024; 25(17).
PMID: 39273498 PMC: 11395538. DOI: 10.3390/ijms25179551.